MFT ( PH NO.: 35100 ) LIDOCAINE/ LIGNOCAINE 1. 73- 2 Percent W/ V CLOTRIMAZOLE 1. 0 Percent OFLOXACIN 0. 30 Percent W/ V BECLOMETHASONE DIPROPIONATE 0. 25 Percent W/ V EAR DROPS
Secunderabad, Telangana, India
Important Dates
Bid submission started
Sept. 14, 2024, 4:18 p.m.
Bid submission ended
Sept. 27, 2024, 8 p.m.
Price Information
Price
Unknown
EMD
0.0
Tender Description:
Item Description: (ph no.:35100) lidocaine/ lignocaine 1.73 -2% w/v + clotrimazole 1.0% + ofloxa cin 0.30% w/v + beclomethasone dipropionate 0.25% w/v ear drops ]
Tender Type:
open
Dates:
Published on
Sept. 14, 2024, 4:18 p.m.
Bid Opening Date
Sept. 27, 2024, 8 p.m.
Doc Download started
Sept. 14, 2024, 4:18 p.m.
Doc Download ended
Sept. 27, 2024, 8 p.m.
Documents
Sign up to access Documents
START A FREE 7-DAY TRIAL
Department & Other Tender Information
Sign up to access Tender Information
START A FREE 7-DAY TRIAL
Similar Tenders
TELANGANA
MFT ( PH NO.: 35100 ) LIDOCAINE/ LIGNOCAINE 1. 73- 2 % W/ V + CLOTRIMAZOLE 1. 0 % + OFLOXACIN 0. 30 % W/ V + BECLOMETHASONE DIPROPIONATE 0. 25 % W/ V EAR DROPS
Expires on 27th Sep, 2024
₹ Not Specified.
MAHARASHTRA
( NED- DRUGS ) ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 % w/ v, Clotrimazole 1. 0 % + Ofloxacin 0. 30 % w/ v + Beclomethasone Dipropionate 0. 25 % w/ v Ear drops
Expires on 24th Sep, 2024
₹ Not Specified.
TELANGANA
( DIV/ SC, DRUG ) ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 % w/ v, Clotrimazole 1. 0 % + Ofloxacin 0. 30 % w/ v + Beclomethasone Dipropionate 0. 25 % w/ v Ear drops
Expires on 23rd Sep, 2024
₹ Not Specified.
TELANGANA
( DIV/ SC, DRUG ) ( PH NO.: 35100 ) Lidocaine/ Lignocaine 1. 73- 2 Percent w/ v, Clotrimazole 1. 0 Percent Ofloxacin 0. 30 Percent w/ v Beclomethasone Dipropionate 0. 25 Percent w/ v Ear s
Expires on 23rd Sep, 2024
₹ Not Specified.
TELANGANA
Item Description: ( ned- drugs ) ( ph no.: 35100 ) lidocaine/ lignocaine 1. 73- 2 % w/ v, clotrimazole 1. 0 % + ofloxacin 0. 30 % w/ v + beclomethasone dipropionate 0. 25 % w/ v ear drops ]
Expires on 24th Sep, 2024
₹ Not Specified.